Key Insights

Highlights

Treatment Research

2 treatments under study, led by Digoxin

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Unknown1
Terminated1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05014087Phase 2Terminated

Digoxin In Treatment of Alcohol Associated Hepatitis

NCT04159441UnknownPrimary

Hepatotoxicity of Antituberculosis Therapy (HAT) Study

Showing all 2 trials

Research Network

Common Treatments

  • Digoxin1
  • None Intervetion1

Active Sponsors

  • Yale University1
  • Huashan Hospital1

Top Investigators

Related Conditions

  • Acute Alcoholic Hepatitis1
  • Alcoholinduced Disorders1
  • Steatohepatitis Caused By Ingestible Alcohol1

Activity Timeline